Target intelligence / Profile preview

Heterogeneous nuclear ribonucleoprotein C pseudogene 10 (HNRNPCP10)

Target
HNRNPCP10
Molecular classification
Pseudogene
01

Overview

Heterogeneous nuclear ribonucleoprotein C pseudogene 10 (HNRNPCP10) is a **pseudogene** derived from the HNRNPC gene, which encodes heterogeneous nuclear ribonucleoprotein C (C1/C2), a nuclear protein involved in mRNA processing and regulation[1][4]. As a pseudogene, HNRNPCP10 has sequence similarity to its parental protein-coding gene but typically contains mutations or truncations that prevent it from encoding a functional protein[3][5]. There is no evidence that HNRNPCP10 encodes a functional protein, nor is it recognized as a therapeutic target, receptor, enzyme, or druggable protein. Pseudogenes, in general, can act as regulatory molecules by functioning as competitive endogenous RNAs or through other RNA-mediated mechanisms, potentially influencing gene expression in health and disease[5]; however, there is no specific evidence for HNRNPCP10 playing such a role. Thus, HNRNPCP10 is not a validated therapeutic target or biomarker. Key points: - HNRNPCP10 is a **pseudogene**, not an active receptor, enzyme, or drug target. - There is **no evidence of protein product, therapeutic targeting, or specific disease association**. - Any biological significance would be through **RNA-based regulatory roles**, but no such role is known for HNRNPCP10[5]. - This entry is likely only of interest in genomic or transcriptomic annotation projects, not in drug discovery or therapeutic contexts.

Other names
HNRNPCP10Heterogeneous nuclear ribonucleoprotein C (C1/C2) pseudogeneHNRNPC pseudogene 10hnRNP C pseudogene 10
02

Biological functions

Other (pseudogenes can act as regulatory RNAs, but no direct biological function has been established for HNRNPCP10 itself[5])
03

Disease associations

Other (pseudogenes can be transcribed and may have a regulatory role in cancer or other diseases in some contexts, but there is no direct evidence for HNRNPCP10[5])

Beyond the preview

Go deeper on Heterogeneous nuclear ribonucleoprotein C pseudogene 10 (HNRNPCP10).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein C pseudogene 10 (HNRNPCP10).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call